We are live on ! Find out more
MBVX

MABVAX THERAPEUTICS HLDGS INC
MBVX

Delisted

MBVX was delisted on the 10th of July, 2018.

Back to rankings

7 hedge funds and large institutions have $281K invested in MABVAX THERAPEUTICS HLDGS INC in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 7 → 7 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.19% less ownership

Funds ownership: 1.52% → 1.33% (-0.19%)

31% less capital invested

Capital invested by funds: $405K → $281K (-$124K)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$117K
2
DRD
Dennis R. Delaney
+$38.1K
3
Deutsche Bank
Deutsche Bank
Germany
+$972

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$201K
2
TRCT
Tower Research Capital (TRC)
New York
-$1K
3
UBS Group
UBS Group
Switzerland
-$1K

MBVX Hedge Fund Activity: Q4 2016 in Review

7 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in MABVAX THERAPEUTICS HLDGS INC (MBVX) for Q4 2016, worth a combined $281K — down 31% from $405K a quarter earlier.

Fund positioning in MBVX was balanced in Q4 2016: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $117K. The largest seller was Virtu KCG Holdings, cutting an estimated $201K.

  • 7 institutional investors held MABVAX THERAPEUTICS HLDGS INC (MBVX) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $281K of MABVAX THERAPEUTICS HLDGS INC stock for Q4 2016, down 31% quarter-over-quarter.
  • 2 funds opened new MABVAX THERAPEUTICS HLDGS INC positions in Q4 2016 and 2 closed out, a net change of 0 holders.
  • The largest MABVAX THERAPEUTICS HLDGS INC buyer in Q4 2016 was Millennium Management, an estimated $117K added.
  • The largest MABVAX THERAPEUTICS HLDGS INC seller in Q4 2016 was Virtu KCG Holdings, an estimated $201K sold.

Based on aggregated 13F filings for Q4 2016.